Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
212844-53-6
|
| gptkbp:hasInChIKey |
QJQYQJXKQKJZQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C18H23N5O
|
| gptkbp:hasSMILES |
CC(C)n1c2ncnc(Nc3ccccc3)c2nc1NCCO
|
| https://www.w3.org/2000/01/rdf-schema#label |
purvalanol A
|
| gptkbp:inhibitedBy |
gptkb:CDK2
gptkb:CDK4 gptkb:CDK6 gptkb:CDK1 |
| gptkbp:IUPACName |
6-benzylamino-2-(2-hydroxyethylamino)-9-isopropylpurine
|
| gptkbp:meltingPoint |
>200°C
|
| gptkbp:molecularWeight |
325.41 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL25436
412073 468595 |
| gptkbp:type |
purine analogue
cyclin-dependent kinase inhibitor |
| gptkbp:used_in |
cancer research
|
| gptkbp:bfsParent |
gptkb:cdc2
|
| gptkbp:bfsLayer |
5
|